Icecure Medical Ltd. current report, Q4 FY2021

Business Context and Reporting Period

This Form 6-K filing by Icecure Medical Ltd. covers the month of November 2021, specifically dated November 29, 2021. The registrant is a foreign private issuer based in Caesarea, Israel, filing under Rule 13a-16 of the Securities Exchange Act of 1934.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.

Material Changes

The primary material change disclosed is a corporate governance update regarding executive leadership. The company announced the appointment of Merav Nir Dotan to the position of Vice President of Human Resources.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items. The document serves solely to disseminate the press release regarding the executive appointment.

Investor Verification Checklist

  • Verify the background and qualifications of the newly appointed Vice President of Human Resources, Merav Nir Dotan.
  • Confirm the effective date of the appointment and any potential impact on existing HR leadership structures.
  • Review the full text of the press release (Exhibit 99.1) for additional context not summarized in the filing header.